BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24729481)

  • 1. Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function.
    Mouradian M; Kikawa KD; Dranka BP; Komas SM; Kalyanaraman B; Pardini RS
    Mol Carcinog; 2015 Sep; 54(9):810-20. PubMed ID: 24729481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
    Farabegoli F; Vettraino M; Manerba M; Fiume L; Roberti M; Di Stefano G
    Eur J Pharm Sci; 2012 Nov; 47(4):729-38. PubMed ID: 22954722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
    Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
    J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
    Schley PD; Jijon HB; Robinson LE; Field CJ
    Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dietary ω-3 Polyunsaturated Fatty Acid DHA on Glycolytic Enzymes and Warburg Phenotypes in Cancer.
    Manzi L; Costantini L; Molinari R; Merendino N
    Biomed Res Int; 2015; 2015():137097. PubMed ID: 26339588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docosahexaenoic Acid-mediated Inhibition of Heat Shock Protein 90-p23 Chaperone Complex and Downstream Client Proteins in Lung and Breast Cancer.
    Mouradian M; Ma IV; Vicente ED; Kikawa KD; Pardini RS
    Nutr Cancer; 2017 Jan; 69(1):92-104. PubMed ID: 27880046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma.
    Fischer AP; Miles SL
    Biomed Pharmacother; 2017 Feb; 86():502-513. PubMed ID: 28012930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
    Knouzy B; Dubourg L; Baverel G; Michoudet C
    J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric nanocapsules prevent oxidation of core-loaded molecules: evidence based on the effects of docosahexaenoic acid and neuroprostane on breast cancer cells proliferation.
    Roy J; Oliveira LT; Oger C; Galano JM; Bultel-Poncé V; Richard S; Guimaraes AG; Vilela JM; Andrade MS; Durand T; Besson P; Mosqueira VC; Le Guennec JY
    J Exp Clin Cancer Res; 2015 Dec; 34():155. PubMed ID: 26689718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response.
    Vibet S; Goupille C; Bougnoux P; Steghens JP; Goré J; Mahéo K
    Free Radic Biol Med; 2008 Apr; 44(7):1483-91. PubMed ID: 18267129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
    Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
    Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
    Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel biologically active acid stable liposomal formulation of docosahexaenoic acid in human breast cancer cell lines.
    Skibinski CG; Das A; Chen KM; Liao J; Manni A; Kester M; El-Bayoumy K
    Chem Biol Interact; 2016 May; 252():1-8. PubMed ID: 27041074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.
    Mahéo K; Vibet S; Steghens JP; Dartigeas C; Lehman M; Bougnoux P; Goré J
    Free Radic Biol Med; 2005 Sep; 39(6):742-51. PubMed ID: 16109304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin A on the energy metabolism of breast cancer cells.
    Rodrigues MF; Carvalho É; Pezzuto P; Rumjanek FD; Amoêdo ND
    J Cell Biochem; 2015 May; 116(5):797-808. PubMed ID: 25510910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells.
    Motawi TM; Sadik NA; Fahim SA; Shouman SA
    Chem Biol Interact; 2015 May; 233():147-56. PubMed ID: 25863232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association.
    Rogers KR; Kikawa KD; Mouradian M; Hernandez K; McKinnon KM; Ahwah SM; Pardini RS
    Carcinogenesis; 2010 Sep; 31(9):1523-30. PubMed ID: 20525880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.